Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ohr Pharmaceutical Inc.
Fiscal year is October-September. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 20,443 83,484 737,022 1.18M
COGS excluding D&A 0 0 0 649,293 1.09M
Depreciation & Amortization Expense 0 20,443 83,484 87,729 91,145
Depreciation 0 850 5,004 9,456 13,356
Amortization of Intangibles 0 19,593 78,480 78,273 77,789
Gross Income 0 (20,443) (83,484) (737,022) (1.18M)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 932,883 995,148 1.16M 2.55M 3.44M
Research & Development 0 234,428 521,969 1.55M 2.53M
Other SG&A 932,883 760,720 637,948 1M 907,593
Other Operating Expense 0 0 0 0 0
Unusual Expense (64,443) (1.48M) 3.93M (1.83M) 1.12M
EBIT after Unusual Expense 64,443 1.48M (3.93M) 1.83M (1.12M)
Non Operating Income/Expense 29,788 50,875 72,177 112 90,759
Non-Operating Interest Income 0 - - 0 0
Equity in Affiliates (Pretax) - - 0 - 0
Interest Expense 25,797 21,493 2,433 1,817 4,689
Gross Interest Expense 25,797 21,493 2,433 1,817 4,689
Interest Capitalized 0 0 0 0 0
Pretax Income (864,449) 494,377 (5.1M) (1.45M) (5.65M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (864,449) 494,377 (5.1M) (1.45M) (5.65M)
Minority Interest Expense 0 0 0 0 0
Net Income (864,449) 494,377 (5.1M) (1.45M) (5.65M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries (864,449) 494,377 (5.1M) (1.45M) (5.65M)
Preferred Dividends 0 0 - 0 0
Net Income Available to Common (864,449) 494,377 (5.1M) (1.45M) (5.65M)
EPS (Basic) (0.09) 0.06 (0.39) (0.09) (0.30)
Basic Shares Outstanding 8.42M 10.94M 12.89M 14.24M 18.71M
EPS (Diluted) (0.09) 0.06 (0.39) (0.09) (0.30)
Diluted Shares Outstanding 8.42M 10.94M 12.89M 14.24M 18.71M
EBITDA (932,883) (995,148) (1.16M) (3.2M) (4.53M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.